Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-09-09T20:00:02.000Z.
Consensus retrieved: 2026-09-10T02:40:36.983Z. This records retrieval, including cache reads, rather than vendor publication. A quote earlier than this retrieval cannot support current forward valuation.
Quote observation: 2026-09-09T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0a1af177dd96d49ca53a5309a4ed37ef62cd499f62d702ad29a1304b9f41d64c
FORWARD PE RATIO
N/A
Baxter International Inc.
Market Cap
$12.61B
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Baxter International Inc. (BAX) | $12.61B | N/A |
| Penumbra, Inc. (PEN)vs › | $12.59B | N/A |
| The Cooper Companies, Inc. (COO)vs › | $12.38B | N/A |
| Encompass Health Corporation (EHC)vs › | $12.05B | N/A |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.41B | N/A |
| DaVita Inc. (DVA)vs › | $11.75B | N/A |
| Revvity, Inc. (RVTY)vs › | $13.82B | N/A |
| Bio-Techne Corporation (TECH)vs › | $11.31B | N/A |
| Align Technology, Inc. (ALGN)vs › | $10.95B | N/A |
| Tempus AI, Inc. (TEM)vs › | $10.74B | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus next-FY EPS
At today's $24.39 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $2.05 | $1.98 – $2.08 | 8 | 11.9x |
| 2027-12-31 | $2.04 | $1.70 – $2.15 | 9 | 11.9x |
| 2028-12-31 | $2.17 | $1.44 – $3.09 | 3 | 11.3x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
